Owlet partners with Rhapsody on electronic health record integration of BabySat

Owlet (OWLT) announced a partnership with Rhapsody to securely connect infant health insights from Owlet’s FDA-cleared, prescription pulse oximeter, BabySat, directly into their existing electronic health record workflows. “True interoperability isn’t just about moving data, it’s about making that data meaningful in the moments that matter,” said Sagnik Bhattacharya, CEO of Rhapsody. “By connecting Owlet’s clinically-validated monitoring data directly into the EHR, we’re giving clinicians a fuller view of their youngest patients, and helping families feel more connected to their child’s care team.”